Evidence map›Paper›PMID 37915460›Full record

ArticleGlobal medical genetics2023

The Evaluation of Prognostic Value and Immune Characteristics of Ferroptosis-Related Genes in Lung Squamous Cell Carcinoma.

Jialin Su, Shuhua Tan, Houwu Gong, Yongzhong Luo, Tianli Cheng, Hua Yang, Xiaoping Wen, Zhou Jiang, Yuning Li, Lemeng Zhang

Open access · diamondAbstract read
In one paragraph

Article in Global medical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jialin SuThoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
Shuhua TanSchool of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan, People's Republic of China.
Houwu GongCollege of Computer Science and Electronic Engineering, Hunan University, Changsha, People's Republic of China.
Yongzhong LuoThoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
Tianli ChengThoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
Hua YangThoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
Xiaoping WenThoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
Zhou JiangThoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
Yuning LiSchool of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan, People's Republic of China.
Lemeng ZhangThoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
Hunan Cancer Hospital · CNHunan University of Science and Technology · CNHunan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antitumor immunityferroptosisimmune infiltrationlung squamous carcinomaprognostic model

Identifiers

PMID37915460
PMCPMC10615648
OpenAlexW4388098694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.